domingo, setembro 13, 2026
Moda Global
  • Home
  • Quem Somos
  • Últimas Notícias
  • Entretenimento
  • Geral
  • Contato
No Result
View All Result
  • Home
  • Quem Somos
  • Últimas Notícias
  • Entretenimento
  • Geral
  • Contato
No Result
View All Result
Moda Global
No Result
View All Result
Home Últimas Notícias

Caneta da Mantecorp, Semavy, chega às farmácias do Brasil

redacao by redacao
12/09/2026
in Últimas Notícias
0 0
0
Caneta da Mantecorp, Semavy, chega às farmácias do Brasil
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Uma nova possibilidade chegou ao mercado para pessoas que estão em busca de tratamento para controle de peso. A Mantecorp anunciou o lançamento de Semavy, caneta de semaglutida que passa a ser distribuída em farmácias de todo o Brasil. O medicamento é aprovado pela Anvisa e traz a proposta de ampliar as possibilidades dentro de uma jornada que vai além da perda de peso.

A chegada da caneta da Mantecorp acontece em um momento em que os medicamento injetáveis de GLP-1 ganharam espaço nas conversas sobre saúde, emagrecimento e qualidade de vida. Para a Mantecorp, no entanto, o tratamento não deve ser encarado apenas como uma mudança na aparência. Transformar o corpo também envolve cuidar da saúde, adotar novos hábitos e contar com acompanhamento profissional ao longo do processo.

(function () {
var AD_UNIT = ‘ld-m-art-r1-01’;
var PLACEMENT = ‘846612’;
var DEVICE = ‘mobile’;
var MIN_H = 280;
var done = false;

function rightDevice() {
var isMobile = window.matchMedia
? window.matchMedia(‘(max-width: 767px)’).matches
: (document.documentElement.clientWidth || 0) < 768;

return DEVICE === 'mobile' ? isMobile : !isMobile;
}

function box() {
return document.getElementById(AD_UNIT);
}

function hide() {
var b = box();
if (b) b.style.display = 'none';
}

function register() {
if (done) return;

done = true;

if (!rightDevice()) {
hide();
return;
}

var b = box();

if (b) {
b.style.minHeight = MIN_H + 'px';
}

window.ANConfig = window.ANConfig || {};
window.ANConfig.placements = window.ANConfig.placements || [];

window.ANConfig.placements.push({
adUnitId: AD_UNIT,
propertyId: '105130',
placementId: PLACEMENT,
data: {},
consent: true,

onLoad: function (adUnitId) {},

onFail: function (adUnitId) {
hide();
}
});

setTimeout(function () {
var c = box();

if (c && !c.getElementsByTagName('iframe').length) {
hide();
}
}, 6000);
}

var C = window.__ldAdConsent;

if (!C) {

C = window.__ldAdConsent = {
subs: [],
fired: false
};

C.granted = function () {
var v = window.LD_AD_CONSENT;

return v === true ||
v === 1 ||
v === 'true';
};

C.fire = function () {

if (C.fired) return;

C.fired = true;

if (C.poll) {
clearInterval(C.poll);
C.poll = null;
}

for (var i = 0; i < C.subs.length; i++) {
try {
C.subs[i]();
} catch (e) {}
}

var inject = function () {

if (document.getElementById('ap-js')) {
return;
}

var ver = new Date()
.toISOString()
.split(':')[0]
.replace(/\D/g, '');

var apjs = document.createElement('script');

apjs.type = 'text/javascript';
apjs.async = true;
apjs.setAttribute('id', 'ap-js');

apjs.src =
'https://central-brazil.ap.giraffa.tech/js/ap-gjanout.js?v=' + ver;

document.head.appendChild(apjs);
};

if (document.readyState === 'loading') {

document.addEventListener(
'DOMContentLoaded',
function () {
setTimeout(inject, 0);
}
);

} else {

setTimeout(inject, 0);

}
};

function onSignal(e) {

if (
(e && e.detail === true) ||
C.granted()
) {
C.fire();
}

}

window.addEventListener(
'ld-ad-consent',
onSignal
);

document.addEventListener(
'ld-ad-consent',
onSignal
);

if (typeof window.__tcfapi === 'function') {

window.__tcfapi(
'addEventListener',
2,
function (tcData, success) {

if (!success || !tcData) {
return;
}

if (
tcData.eventStatus !== 'tcloaded' &&
tcData.eventStatus !== 'useractioncomplete'
) {
return;
}

if (
tcData.purpose &&
tcData.purpose.consents &&
tcData.purpose.consents[1]
) {
C.fire();
}

}
);

}

C.poll = setInterval(function () {

if (C.fired) {

clearInterval(C.poll);
C.poll = null;
return;

}

if (C.granted()) {
C.fire();
}

}, 250);
}

C.subs.push(register);

if (C.fired) {

register();

} else if (C.granted()) {

C.fire();

}

})();

Veja as fotos

Divulgação
Divulgação
Divulgação

Leia Também

Nova caneta emagrecedora começa a ser vendida no Brasil; saiba o valor

Saúde

Nova caneta emagrecedora começa a ser vendida no Brasil; saiba o valor

Caneta emagrecedora fabricada no Brasil começa a ser vendida nesta segunda. Veja preço!

Saúde

Caneta emagrecedora fabricada no Brasil começa a ser vendida nesta segunda. Veja preço!

Caneta emagrecedora: Anvisa aprova 1º concorrente nacional do Ozempic no Brasil

Saúde

Caneta emagrecedora: Anvisa aprova 1º concorrente nacional do Ozempic no Brasil

1ª caneta emagrecedora brasileira: saiba quando deve ser lançada e estimativa de valor

Saúde

1ª caneta emagrecedora brasileira: saiba quando deve ser lançada e estimativa de valor

(function () {
var AD_UNIT = ‘ld-m-art-r1-02’;
var PLACEMENT = ‘846681’;
var DEVICE = ‘mobile’; /* ‘mobile’ or ‘desktop’ */
var MIN_H = 280; /* tallest size listed for this position */
var done = false;

/* This block belongs to one device. Mobile and desktop blocks may both sit in the
same responsive template: each checks the viewport and only the matching one
asks for an ad, so they never both render. Breakpoint 768px, tablets count as
desktop. If your template already renders per device server-side this is simply
a second guard and changes nothing. */
function rightDevice() {
var isMobile = window.matchMedia
? window.matchMedia(‘(max-width: 767px)’).matches
: (document.documentElement.clientWidth || 0) < 768;
return DEVICE === 'mobile' ? isMobile : !isMobile;
}

function box() { return document.getElementById(AD_UNIT); }
function hide() { var b = box(); if (b) b.style.display = 'none'; }

/* Registers this position. Never called without a positive consent answer. */
function register() {
if (done) return;
done = true;
if (!rightDevice()) { hide(); return; }
var b = box();
if (b) b.style.minHeight = MIN_H + 'px'; /* reserve only now, never before */
window.ANConfig = window.ANConfig || {};
window.ANConfig.placements = window.ANConfig.placements || [];
window.ANConfig.placements.push({
adUnitId: AD_UNIT,
propertyId: '105130',
placementId: PLACEMENT,
data: {},
consent: true,
onLoad: function (adUnitId) {},
onFail: function (adUnitId) { hide(); }
});
/* Safety net: if nothing has rendered here shortly, release the space.
No position can leave a permanent blank gap, whatever goes wrong. */
setTimeout(function () {
var c = box();
if (c && !c.getElementsByTagName('iframe').length) hide();
}, 6000);
}

/* One shared coordinator per page, created by whichever block runs first.
Every block registers with it, so when consent arrives they all register in
the SAME tick and the loader is injected once, afterwards. The loader drains
its queue once, so a block that registered late would never be served. */
var C = window.__ldAdConsent;
if (!C) {
C = window.__ldAdConsent = { subs: [], fired: false };

C.granted = function () {
var v = window.LD_AD_CONSENT;
return v === true || v === 1 || v === 'true';
};

C.fire = function () {
if (C.fired) return;
C.fired = true;
if (C.poll) { clearInterval(C.poll); C.poll = null; }
for (var i = 0; i < C.subs.length; i++) {
try { C.subs[i](); } catch (e) {}
}
var inject = function () { /* now, with all of them queued */
if (document.getElementById('ap-js')) return;
var ver = new Date().toISOString().split(':')[0].replace(/\D/g, '');
var apjs = document.createElement('script');
apjs.type = 'text/javascript';
apjs.async = true;
apjs.setAttribute('id', 'ap-js');
apjs.src = 'https://central-brazil.ap.giraffa.tech/js/ap-gjanout.js?v=' + ver;
document.head.appendChild(apjs);
};
/* The loader drains its queue once, so it must not be fetched while the page is
still parsing: blocks further down would register after the drain and be lost.
Consent known before the body parses is the normal returning-visitor case. */
if (document.readyState === 'loading') {
document.addEventListener('DOMContentLoaded', function () { setTimeout(inject, 0); });
} else {
setTimeout(inject, 0);
}
};

function onSignal(e) {
if ((e && e.detail === true) || C.granted()) C.fire();
}
window.addEventListener('ld-ad-consent', onSignal);
document.addEventListener('ld-ad-consent', onSignal); /* the event does not bubble */

/* 2. IAB TCF v2, used automatically if it ever resolves. Purpose 1 gates storing
and accessing information on the device, which ad serving requires. Consent
is required whether or not gdprApplies is set: gdprApplies being false is
never treated as permission. (Measured here 28 Aug 2026: it is true.) */
if (typeof window.__tcfapi === 'function') {
window.__tcfapi('addEventListener', 2, function (tcData, success) {
if (!success || !tcData) return;
if (tcData.eventStatus !== 'tcloaded' &&
tcData.eventStatus !== 'useractioncomplete') return;
if (tcData.purpose && tcData.purpose.consents && tcData.purpose.consents[1]) C.fire();
});
}

/* 1. Your signal. Set window.LD_AD_CONSENT = true when consent is known.
The order does not matter and there is no time limit: this watch runs
until consent arrives or the page is closed. */
C.poll = setInterval(function () {
if (C.fired) { clearInterval(C.poll); C.poll = null; return; }
if (C.granted()) C.fire();
}, 250);
}

C.subs.push(register);
if (C.fired) register(); /* consent already given before this block parsed */
else if (C.granted()) C.fire();
})();

A indicação do tratamento deve ser feita após avaliação médica e precisa estar associado a acompanhamento profissional, alimentação adequada, atividade física e mudanças de hábitos. A proposta da Mantecorp é oferecer também informação e orientação para tornar esse processo mais compreensível e sustentável para quem está em tratamento.

(function () {
var AD_UNIT = ‘ld-m-art-r1-03’;
var PLACEMENT = ‘846688’;
var DEVICE = ‘mobile’; /* ‘mobile’ or ‘desktop’ */
var MIN_H = 280; /* tallest size listed for this position */
var done = false;

/* This block belongs to one device. Mobile and desktop blocks may both sit in the
same responsive template: each checks the viewport and only the matching one
asks for an ad, so they never both render. Breakpoint 768px, tablets count as
desktop. If your template already renders per device server-side this is simply
a second guard and changes nothing. */
function rightDevice() {
var isMobile = window.matchMedia
? window.matchMedia(‘(max-width: 767px)’).matches
: (document.documentElement.clientWidth || 0) < 768;
return DEVICE === 'mobile' ? isMobile : !isMobile;
}

function box() { return document.getElementById(AD_UNIT); }
function hide() { var b = box(); if (b) b.style.display = 'none'; }

/* Registers this position. Never called without a positive consent answer. */
function register() {
if (done) return;
done = true;
if (!rightDevice()) { hide(); return; }
var b = box();
if (b) b.style.minHeight = MIN_H + 'px'; /* reserve only now, never before */
window.ANConfig = window.ANConfig || {};
window.ANConfig.placements = window.ANConfig.placements || [];
window.ANConfig.placements.push({
adUnitId: AD_UNIT,
propertyId: '105130',
placementId: PLACEMENT,
data: {},
consent: true,
onLoad: function (adUnitId) {},
onFail: function (adUnitId) { hide(); }
});
/* Safety net: if nothing has rendered here shortly, release the space.
No position can leave a permanent blank gap, whatever goes wrong. */
setTimeout(function () {
var c = box();
if (c && !c.getElementsByTagName('iframe').length) hide();
}, 6000);
}

/* One shared coordinator per page, created by whichever block runs first.
Every block registers with it, so when consent arrives they all register in
the SAME tick and the loader is injected once, afterwards. The loader drains
its queue once, so a block that registered late would never be served. */
var C = window.__ldAdConsent;
if (!C) {
C = window.__ldAdConsent = { subs: [], fired: false };

C.granted = function () {
var v = window.LD_AD_CONSENT;
return v === true || v === 1 || v === 'true';
};

C.fire = function () {
if (C.fired) return;
C.fired = true;
if (C.poll) { clearInterval(C.poll); C.poll = null; }
for (var i = 0; i < C.subs.length; i++) {
try { C.subs[i](); } catch (e) {}
}
var inject = function () { /* now, with all of them queued */
if (document.getElementById('ap-js')) return;
var ver = new Date().toISOString().split(':')[0].replace(/\D/g, '');
var apjs = document.createElement('script');
apjs.type = 'text/javascript';
apjs.async = true;
apjs.setAttribute('id', 'ap-js');
apjs.src = 'https://central-brazil.ap.giraffa.tech/js/ap-gjanout.js?v=' + ver;
document.head.appendChild(apjs);
};
/* The loader drains its queue once, so it must not be fetched while the page is
still parsing: blocks further down would register after the drain and be lost.
Consent known before the body parses is the normal returning-visitor case. */
if (document.readyState === 'loading') {
document.addEventListener('DOMContentLoaded', function () { setTimeout(inject, 0); });
} else {
setTimeout(inject, 0);
}
};

function onSignal(e) {
if ((e && e.detail === true) || C.granted()) C.fire();
}
window.addEventListener('ld-ad-consent', onSignal);
document.addEventListener('ld-ad-consent', onSignal); /* the event does not bubble */

/* 2. IAB TCF v2, used automatically if it ever resolves. Purpose 1 gates storing
and accessing information on the device, which ad serving requires. Consent
is required whether or not gdprApplies is set: gdprApplies being false is
never treated as permission. (Measured here 28 Aug 2026: it is true.) */
if (typeof window.__tcfapi === 'function') {
window.__tcfapi('addEventListener', 2, function (tcData, success) {
if (!success || !tcData) return;
if (tcData.eventStatus !== 'tcloaded' &&
tcData.eventStatus !== 'useractioncomplete') return;
if (tcData.purpose && tcData.purpose.consents && tcData.purpose.consents[1]) C.fire();
});
}

/* 1. Your signal. Set window.LD_AD_CONSENT = true when consent is known.
The order does not matter and there is no time limit: this watch runs
until consent arrives or the page is closed. */
C.poll = setInterval(function () {
if (C.fired) { clearInterval(C.poll); C.poll = null; return; }
if (C.granted()) C.fire();
}, 250);
}

C.subs.push(register);
if (C.fired) register(); /* consent already given before this block parsed */
else if (C.granted()) C.fire();
})();

Com um valor mais acessível no mercado, a Semavy terá ampla distribuição nacional, além de integrar um ecossistema de cuidado que contempla conteúdos educativos e soluções complementares. A iniciativa busca acompanhar diferentes momentos da jornada e reforçar a importância de utilizar medicamentos aprovados, regularizados e de procedência segura.

n
Fonte: https://portalleodias.com/saude/caneta-da-mantecorp-semavy-chega-as-farmacias-do-brasil

Previous Post

Fachin rejeita pedido de Moraes e mantém para terça julgamento sobre mensagens de Vorcaro

Next Post

5 sinais de que você está no caminho certo, mesmo sem perceber

redacao

redacao

Next Post
5 sinais de que você está no caminho certo, mesmo sem perceber

5 sinais de que você está no caminho certo, mesmo sem perceber

  • Contato
  • Moda Global
  • Quem Somos
  • Sample Page

© 2026 MODA GLOBAL

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Quem Somos
  • Últimas Notícias
  • Entretenimento
  • Geral
  • Contato

© 2026 MODA GLOBAL